Results for immunocompetent translation from English to Maltese

immunocompetent vaccinees
persuni mlaqqmin immunokompetenti

if the organism is pathogenic to humans who are immunocompetent:
jekk l-organiżmu huwa patoġeniku għal bniedem li huma immunocompetent:

immunosuppressive therapy also affects immunocompetent cells as such infused with zalmoxis.
terapija immunosuppressiva taffettwa wkoll ċelluli immunokompetenti bħal dawk infużi b’zalmoxis.

if the micro-organism is pathogenic to humans who are immunocompetent:
jekk il-mikro organiżmu huwiex patoġeniku għall-bnedmin illi huma immunokompetenti:

resistant strains selected during oseltamivir treatment have been isolated from both immunocompetent and immunocompromised patients.
razez reżistenti magħżula waqt il-kura b’oseltamivir kienu iżolati kemm minn pazjenti immunokompetenti kif ukoll minn dawk immunokompromessi.

parenterally administered anidulafungin was effective against candida species in immunocompetent and immunocompromised mouse and rabbit models.
anidalfungin mogħti b’mod parenterali, kien effettiv kontra speċi ta’ candida f’mudelli ta’ ġrieden u fniek immunokompetenti u immunokompromessi.

activity in vivo parenterally administered anidulafungin was effective against candida spp. in immunocompetent and immunocompromised mouse and rabbit models.
attivita in vivo anidalfungin mogħti b. mod parenterali, kien effettiv kontra candida spp. f’ mudelli ta ’ ġrieden u fniek immunokompetenti u immunokompromessi.

criteria (i) - (iii) refer to immunocompetent humans and healthy animals or plants.
kriterji (i) - (iii) jirreferu għal bnedmin immunokompetenti u annimalu u pjanti f'saħħithom.

it is not yet fully established whether immunocompetent individuals who have responded to hepatitis a vaccination will require booster doses as protection in the absence of detectable antibodies may be ensured by immunological memory.
għadu ma ġiex stabbilit jekk individwi immunokompetenti li rrispondew għal tilqima bil-epatite a jinħtieġux doża ta’ rinforz billi fl-assenza ta’ antikorpi evidenti jista jkun li l-protezzjoni tiġi assigurata bil- memorja immunoloġika.

the auc/mic ratio to achieve bacteriostasis in neutropenic mice was at least 16 times that in immunocompetent animals (see section 4.4).
il-proporzjon tal-auc/mic biex tinkiseb batterjostasi fil-ġrieden newtropeniċi kien mill-inqas 16-il darba dak f’annimali immunokompetenti (ara sezzjoni 4.4).

the committee for medicinal products for human use (chmp) decided that aldara’s benefits are greater than its risks for the treatment of external genital and perianal warts (condylomata acuminata), small basal cell carcinomas and nonhyperkeratotic, nonhypertrophic actinic keratoses in immunocompetent adult patients when other topical treatment options are contraindicated or less appropriate.
il-kumitat għal prodotti mediċinali għal użu tal-bniedem (chmp) iddeċieda li l-benefiċċji ta’ aldara huma akbar mir-riskji tagħha għall-kura ta’ felul tal-ġenitali esterni u perianali (condylomata acuminata), karċinomi żgħar taċ-ċellola bażali u keratożi aktinika mhux iperkeratotika, mhux ipertrofika f’pazjenti adulti immunokompetenti meta għażliet ta’ kuri topikali oħra mhux indikati jew anqas addattati.